« Back to Record
Paridaens, R., Dirix, L. Y., Lohrisch, C., Beex, L., Nooij, M., Cameron, D. A., Biganzoli, L., Cufer, T., Duchateau, L., Hamilton, A., Lobelle, J. P., Piccart-Gebhart, M., & European Organization for the Research and Treatment of Cancer (EORTC)- Investigational Drug Branch for Breast Cancer (IDBBC), (2003). Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer. Annals of oncology, 14(9), 1391-1398. doi:10.1093/annonc/mdg362
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/55258



